Digestive Enzymes: Who Actually Needs Them

“Digestive enzymes” straddles two completely different evidence categories that marketing routinely blurs into one. On one side: a real, serious, well-defined medical condition (exocrine pancreatic insufficiency) with a prescription treatment that meaningfully changes people’s lives. On the other: an over-the-counter supplement aisle selling general “supports digestion” enzyme blends to people who, in the large majority of cases, have no diagnosed deficiency at all. This article draws that line.

The short version

• Exocrine pancreatic insufficiency (EPI) is a real, diagnosable, serious medical condition — the pancreas fails to produce enough of the enzymes (lipase, amylase, protease/elastase) needed to digest fat, carbohydrate, and protein, leading to malabsorption, malnutrition, and, left untreated, deficiencies in fat-soluble vitamins. Per Cleveland Clinic, chronic pancreatitis is the leading adult cause (up to 8 in 10 adults with chronic pancreatitis develop EPI) and cystic fibrosis is the leading pediatric cause (nearly 9 in 10 infants with cystic fibrosis develop EPI within the first year).
• EPI has specific diagnostic tests — a fecal elastase test, a fecal fat test, and/or a secretin pancreatic function test — and a specific prescription treatment, pancreatic enzyme replacement therapy (PERT), that Cleveland Clinic describes as able to “greatly reduce” EPI’s uncomfortable digestive symptoms when taken correctly with every meal and snack. This is not the same product category as an over-the-counter “digestive enzyme supplement,” and PERT is a prescription medication, not a supplement.
• For people without a diagnosed enzyme deficiency, the evidence for general over-the-counter digestive enzyme blends is weak. Per Harvard Health, “for most people, there’s little evidence that they do any good” for symptoms like bloating, gas, and bowel irregularity when there isn’t an identifiable underlying deficiency.
• Two specific, narrow over-the-counter enzyme use cases do have real, targeted evidence behind them, and they’re worth distinguishing from the general blends: lactase supplements for lactose intolerance, and alpha-galactosidase supplements (the enzyme in products like Beano) for gas from beans and certain vegetables. These work because they replace one specific, identifiable missing enzyme for one specific, identifiable food-digestion problem — not because “more digestive enzymes” helps digestion broadly.
• A key regulatory distinction most labels don’t make clear: prescription PERT is an FDA-regulated drug; over-the-counter digestive enzyme supplements are not. Per Harvard Health, OTC enzyme supplements are not regulated by the FDA as medications, meaning there’s no guarantee about how they’re manufactured or the actual enzyme content of what’s in the capsule — a quality-control gap distinct from the separate question of whether taking enzymes helps a given symptom at all.
• The practical takeaway: if a reader has an actual diagnosed condition affecting pancreatic function (chronic pancreatitis, cystic fibrosis, or certain GI surgeries), the conversation is with a doctor about prescription PERT, not a supplement aisle. If a reader doesn’t have a diagnosed deficiency and is taking a general OTC “digestive enzyme” blend for everyday bloating, they’re taking a product with little evidence behind that specific use — though a lactase or alpha-galactosidase product for a specific, identified food trigger is a different and better-supported story.

What exocrine pancreatic insufficiency actually is

The pancreas is the body’s main source of digestive enzymes: lipase (fat), amylase (carbohydrate), and protease/elastase (protein), released into the small intestine as food arrives. When the pancreas can’t produce enough of these enzymes, or the enzymes don’t function correctly, food passes through the digestive tract in an incompletely broken-down state and the body can’t absorb the nutrients it needs — a condition called exocrine pancreatic insufficiency (EPI).

EPI is not a vague or informal label; it’s a recognized diagnosis with known causes, most centrally chronic pancreatitis in adults (per Cleveland Clinic, as many as 8 in 10 adults with chronic pancreatitis develop EPI) and cystic fibrosis in children (nearly 9 in 10 infants with cystic fibrosis develop EPI within the first year). Other documented causes include celiac disease, diabetes, inflammatory bowel disease, pancreatic cancer, and certain digestive-tract surgeries, including weight-loss surgery. Left untreated, EPI’s fat-malabsorption problem specifically can lead to deficiencies in the fat-soluble vitamins A, D, E, and K, along with broader malnutrition symptoms: fatigue, unexplained weight loss, muscle loss, and more.

How EPI is actually diagnosed, and why that matters for label-reading

Cleveland Clinic describes three specific pancreas function tests used to diagnose EPI: a fecal elastase test (checking stool for the elastase enzyme; little or none can indicate EPI), a fecal fat test (measuring fat content in stool), and a secretin pancreatic function test (measuring how the pancreas responds to a hormone that triggers enzyme release). This matters for the same reason a defined diagnostic test mattered in this project’s companion “leaky gut” article: EPI is a condition a doctor can actually test for and confirm, which is a fundamentally different footing than “I feel bloated and assume I’m low on digestive enzymes.” A reader with genuinely concerning or persistent digestive symptoms, especially oily or floating stools, unexplained weight loss, or symptoms alongside a known risk factor like chronic pancreatitis or cystic fibrosis, is a candidate for this kind of testing with a doctor — not a candidate for self-treating with an OTC supplement.

Once diagnosed, treatment is pancreatic enzyme replacement therapy (PERT), a prescription medication containing the same enzyme types the pancreas isn’t producing enough of. Cleveland Clinic is direct that EPI “can’t be cured,” but PERT “can greatly reduce uncomfortable digestive symptoms” when taken correctly with every meal and snack, alongside dietary changes (a high-calorie, high-fat diet, since fat helps absorb nutrients) and often prescription vitamin supplementation for the fat-soluble vitamins EPI patients struggle to absorb.

What the evidence says for people without a diagnosed deficiency

This is where most over-the-counter “digestive enzyme” products actually live, and it’s a much thinner evidence picture. Per Harvard Health’s own direct assessment: digestive enzyme supplements “purportedly fix all sorts of abdominal symptoms, including bloating, gas, and bowel irregularity, as well as overall gut health. However, for most people, there’s little evidence that they do any good.” The reasoning follows directly from the EPI discussion above: most people without a diagnosed pancreatic or enzyme-specific problem are already producing enough of their own digestive enzymes, so adding more from a supplement isn’t correcting a deficiency that exists in the first place.

There are two specific, well-supported exceptions, and they’re worth naming because they’re genuinely different from the general blends:

Lactase supplements (such as Lactaid) directly replace the enzyme needed to digest lactose, the sugar in milk and dairy products, for people whose small intestine doesn’t make enough of it on its own. This is a specific enzyme addressing a specific, identifiable, common deficiency (lactose intolerance), and per Harvard Health this is a legitimate, evidence-supported use.

Alpha-galactosidase supplements (such as Beano) can reduce gas and bloating from the specific sugars found in beans and certain vegetables, for people who have difficulty digesting those particular sugars. Same pattern: one specific enzyme, addressing one specific, identifiable digestive gap, rather than a broad “supports digestion” claim.

The difference between these two products and a general multi-enzyme “digestive support” blend isn’t marketing positioning — it’s that lactase and alpha-galactosidase are targeting an enzyme gap that’s actually common and identifiable (most adults have at least some degree of reduced lactase production, and the sugars in beans are broadly hard to digest for nearly everyone), whereas a general blend marketed for everyday bloating in someone with no identified deficiency is not targeting anything specific at all.

What we could not check

• We read Harvard Health’s and Cleveland Clinic’s overview content in full, directly — both are strong, current, institutionally credible sources, and the primary basis for this article’s central claims.
• We did not independently pull and read a randomized controlled trial or systematic review specifically testing general OTC digestive enzyme blends against placebo in people without diagnosed deficiency — Harvard Health’s “little evidence” assessment is a clinical summary judgment from a practicing physician (chief medical editor, Harvard Health Publishing), not a citation to a specific meta-analysis; a stronger version of this article would locate and cite the specific trials (or absence of trials) underlying that assessment.
• We did not independently pull and read primary trial evidence for pancreatic enzyme replacement therapy (PERT) efficacy — Cleveland Clinic’s description of PERT’s benefit is accepted as an institutionally reliable clinical summary, not verified against a specific trial or meta-analysis directly in this research pass.
• This article does not evaluate any specific commercial digestive enzyme product or brand, nor does it cover every possible enzyme-deficiency scenario (for example, sucrase-isomaltase deficiency, a separate and much rarer inherited condition, was not researched for this piece).

Our rating, and why

Split, deliberately. Prescription pancreatic enzyme replacement therapy for diagnosed exocrine pancreatic insufficiency sits at the strong end of the evidence spectrum — a real, serious, diagnosable disease with a real, disease-modifying treatment. General over-the-counter “digestive enzyme” blends marketed for everyday bloating or “gut support” in people without a diagnosed deficiency sit at the weak end, per Harvard Health’s own direct assessment. Two narrow OTC exceptions, lactase and alpha-galactosidase, sit in between: real, targeted, reasonably well-supported evidence for one specific, identifiable digestive gap each. A single “digestive enzymes: yes or no” verdict would misrepresent all three of these very different situations, which is exactly the kind of flattening this project’s article_fields() evidence-rating architecture struggles to represent cleanly (see prior notes in the glucosamine/chondroitin and osteoarthritis-vs-stiffness articles for the same recurring gap).

Sources

1. LeWine HE. Can taking enzyme supplements help soothe my bloating? Harvard Health Publishing. Published 2022-11-01. https://www.health.harvard.edu/healthy-aging-and-longevity/can-taking-enzyme-supplements-help-soothe-my-bloating (read in full directly)
2. Cleveland Clinic. Exocrine Pancreatic Insufficiency (EPI). https://my.clevelandclinic.org/health/diseases/21577-exocrine-pancreatic-insufficiency-epi (read in full directly; medically reviewed, last updated 2021-06-10)